SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-24-000537
Accepted
2024-02-27 00:15:48
Documents
1
Effectiveness Date
2024-02-26
Registration Form
POS AM
Reference AccNo

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 612
  Complete submission text file 9999999995-24-000537.txt   1855
Mailing Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098
Business Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-232771 | Film No.: 24681786
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)